CSMD1 expression were sought by studies of CSMD1 mRNA and DNA in rapidly-frozen autopsy samples of frontal cortex of European American individuals who died without brain disease. All brain samples were supplied anonymously from tissue banks at the University of Maryland (http://medschool.umaryland.edu/btbank/) and Johns Hopkins University (http:// pathology.jhu.edu/department/services/consults/neuropath.cfm). RNAs were prepared with the RNeasy lipid tissue mini kits (Qiagen), cDNA was synthesized with SuperScript III First Strand Synthesis Supermix (Invitrogen) and levels of mRNAs were assessed by quantitative RT-PCR using SybrGreen master mix (Applied Biosystems), conditions from the manufacturer’s protocol and oligonucleotide primers (sequences available from authors on request) that targeted the dominant long CSMD1 mRNA isoform (http://www.ncbi.nlm.nih.gov/IEB/ Research/Acembly/av.cgi?db = human q=CSMD1) and the reference genes glyceraldehyde3-phosphate dehydrogenase (GAPDH), hypoxanthine phosphoribosyltransferase 1 (HPRT1) and ubiquitin C (UBC). DNA was extracted from brain samples using ZM241385MedChemExpress ZM241385 Qiagen kits [29], and subjected to multiplexed SNP genotyping using Sequenom panels and oligonucleotides (S1 Table) for 38 SNPs distributed through the gene. The simple sequence repeat that is annotated as rs71534387 was amplified using oligonucleotide primers, polymerase chain reaction conditions 1X PCR Gold buffer (Invitrogen), 0.8 mM dNTP mix, 1.5 mM MgCl2, 0.4M forward and reverse primers and 0.25 units Amplitaq Gold enzyme (Invitrogen). Amplimers and oligonucleotides provided clear peaks every 3 bp after separation using an Applied Biosystems 3730xl instrument with Liz500 size standard (performed by Genewiz, Inc.). Peaks were analyzed using Peak Scanner software and genotypes determined for each DNA sample.Mouse modelsInitial constitutive csmd1 homozygous knockout (KO), heterozygous knockout and littermate wildtype animals were produced by heterozygote x heterozygote crosses from mice that were originally created by Lexicon pharmaceuticals, distributed by Taconic Farms (TF0137) and described by others [21,27]. Embryonic stem cells derived from 129SvEvBrd mice replaced a 1,070 bp genomic sequence of the csmd1 exon 1 ntron 1 junction with a LacZ/Neo selection cassette expressed in frame with the start of the CSMD1 protein-coding sequence. The “mixed background” mice derived from these ES cells were maintained on mixed genetic backgroundsPLOS ONE | DOI:10.1371/journal.pone.0120908 July 14,3 /CSMD1 Variants and Addictionthat included 129 and B6 ancestries (the exact B6 substrain unknown) as reflected by varying coat colors (black, agouti, and white individuals) [21,27]. Following initial testing and identification of substantial mouse to mouse variability, these mixed background csmd1 KO mice were backcrossed to C57Bl/6J mice for 4 generations and then to Tg(Thy1-EGFP)MJrs mice (C57Bl/ 6J mice expressing eGFP under control of the Thy1 promoter) for the fifth generation, so that less than 2 of the initial 129 DNA was Grazoprevir web present. These backcrossed mice, termed csmd1 mice here, of both sexes were tested at 118 ?49 days of age. All mouse breeding, care and experimentation was approved by the NIDA-IRP Animal Care and Use Committee.Mouse behavioral studiesMotor. Muscle strength/motor persistence test: 9?0 mice of each genotype, half of them males and half females were tested to determine the time during which they could support their weight by holding ont.CSMD1 expression were sought by studies of CSMD1 mRNA and DNA in rapidly-frozen autopsy samples of frontal cortex of European American individuals who died without brain disease. All brain samples were supplied anonymously from tissue banks at the University of Maryland (http://medschool.umaryland.edu/btbank/) and Johns Hopkins University (http:// pathology.jhu.edu/department/services/consults/neuropath.cfm). RNAs were prepared with the RNeasy lipid tissue mini kits (Qiagen), cDNA was synthesized with SuperScript III First Strand Synthesis Supermix (Invitrogen) and levels of mRNAs were assessed by quantitative RT-PCR using SybrGreen master mix (Applied Biosystems), conditions from the manufacturer’s protocol and oligonucleotide primers (sequences available from authors on request) that targeted the dominant long CSMD1 mRNA isoform (http://www.ncbi.nlm.nih.gov/IEB/ Research/Acembly/av.cgi?db = human q=CSMD1) and the reference genes glyceraldehyde3-phosphate dehydrogenase (GAPDH), hypoxanthine phosphoribosyltransferase 1 (HPRT1) and ubiquitin C (UBC). DNA was extracted from brain samples using Qiagen kits [29], and subjected to multiplexed SNP genotyping using Sequenom panels and oligonucleotides (S1 Table) for 38 SNPs distributed through the gene. The simple sequence repeat that is annotated as rs71534387 was amplified using oligonucleotide primers, polymerase chain reaction conditions 1X PCR Gold buffer (Invitrogen), 0.8 mM dNTP mix, 1.5 mM MgCl2, 0.4M forward and reverse primers and 0.25 units Amplitaq Gold enzyme (Invitrogen). Amplimers and oligonucleotides provided clear peaks every 3 bp after separation using an Applied Biosystems 3730xl instrument with Liz500 size standard (performed by Genewiz, Inc.). Peaks were analyzed using Peak Scanner software and genotypes determined for each DNA sample.Mouse modelsInitial constitutive csmd1 homozygous knockout (KO), heterozygous knockout and littermate wildtype animals were produced by heterozygote x heterozygote crosses from mice that were originally created by Lexicon pharmaceuticals, distributed by Taconic Farms (TF0137) and described by others [21,27]. Embryonic stem cells derived from 129SvEvBrd mice replaced a 1,070 bp genomic sequence of the csmd1 exon 1 ntron 1 junction with a LacZ/Neo selection cassette expressed in frame with the start of the CSMD1 protein-coding sequence. The “mixed background” mice derived from these ES cells were maintained on mixed genetic backgroundsPLOS ONE | DOI:10.1371/journal.pone.0120908 July 14,3 /CSMD1 Variants and Addictionthat included 129 and B6 ancestries (the exact B6 substrain unknown) as reflected by varying coat colors (black, agouti, and white individuals) [21,27]. Following initial testing and identification of substantial mouse to mouse variability, these mixed background csmd1 KO mice were backcrossed to C57Bl/6J mice for 4 generations and then to Tg(Thy1-EGFP)MJrs mice (C57Bl/ 6J mice expressing eGFP under control of the Thy1 promoter) for the fifth generation, so that less than 2 of the initial 129 DNA was present. These backcrossed mice, termed csmd1 mice here, of both sexes were tested at 118 ?49 days of age. All mouse breeding, care and experimentation was approved by the NIDA-IRP Animal Care and Use Committee.Mouse behavioral studiesMotor. Muscle strength/motor persistence test: 9?0 mice of each genotype, half of them males and half females were tested to determine the time during which they could support their weight by holding ont.
